General discussion, page-689

The trial results in a few weeks are not the results we need to kick the share price.
The trials happening at the moment are pre-clinical trials of the individual components of what will eventually become the combined formulation. So really a trial to help develope the goldilocks formula for the combined formulation. So in essence, the first lot of results do not reflect the combination furmula that will eventually be used.

The next stage of this trial is the pre-clinical trial of the combined formulation. This is to test for toxicity vs doseage size etc ie: prove its safe to use in a in human trial (this will be the Phase 1 trial that will happen later). Maybe the pre-clinical trial will show that the combined formulation has positive effects on ARDS in rats (well insert animal tupe used in trial here). And postive results in rats dont always transfer to good results in human. However this is somewhat derisked as the components are already well known.

It wont be until in Human trial results are known that the share price will move.

Sorry to be pedandtic here, but i think we need realistic expectations of what is happening. We still need patience at the moment.

The OSA and TBI trials, when started, are phase 2a trials. These results will be important to the share price, and will allow IHL to get product to market.